Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4079_Библиотеки_им_академика_М_И_Перельмана
.pdf
Index
A
access, 24
acid, xi, 122, 134, 137, 139
active site, 59, 60
AD, 136
ADC, 147
adenine, 125
adhesion, 40, 49, 66
adjustment, 13, 65, 120
adolescents, 138
adults, 86, 154, 155
African-American, 76, 125
age, vii, viii, xi, 1, 2, 3, 5, 8, 14, 37, 40, 48,
63, 69, 70, 71, 88, 98, 105, 106, 109,
113, 119, 122, 123, 128, 129, 130, 131,
132, 133, 134, 147
aggregation, 44, 66, 104
alanine, 125
algorithm, 9, 17
allele, 57, 61, 64, 68, 69, 71, 72, 77, 93,
125, 126, 127, 133, 134
alteplase, 110
alters, 63
American Heart Association, 149, 155
amino acid(s), 58, 99, 125, 126
amniotic fluid, 125
anatomy, 25, 145
angiogenesis, 98
angiography, 26, 108, 128, 143, 148, 149,
155
angioplasty, 43
ankles, 25
ANOVA, 129
antibody, 44
anticoagulant, xi, 2, 7, 23, 30, 57, 60, 62,
70, 75, 83, 86, 87, 88, 89, 91, 94, 96, 98,
104, 105, 106, 107, 110, 111, 112, 113,
116, 117, 119
anticoagulate, viii, 21, 26
anticoagulation, viii, ix, xii, 8, 9, 21, 26, 27,
28, 31, 35, 38, 42, 43, 44, 50, 51, 52,
104, 110, 111, 112, 113, 114, 115, 142,
150
antigen, 60, 62, 63, 65, 98, 100
antiphospholipid antibodies, 106, 115
antiphospholipid syndrome, 108, 150
APC, 56, 58, 61, 62, 63, 67, 68, 69, 70, 77,
100, 104, 105
aphasia, 145
arginine, 56, 57
arteriovenous malformation, 153
artery(ies), 2, 18, 22, 108, 119, 123, 145
Asian countries, 109
assessment, 15, 30, 31
asymptomatic, viii, 12, 13, 21, 22, 23, 25,
28, 38, 41, 114, 118, 145
atherosclerosis, 93, 98, 119, 126, 128
ATLAS, 9, 17
https://t.me/med1917
Index
158
autoimmune diseases, 49, 107
autopsy, 41, 145
autosomal dominant, 60
B
bacteremia, 51
benefits, 13
bilateral, 10, 19
bioavailability, 42
biological activity, 63
biological fluids, 124
biopsy, 7
bleeding, 4, 5, 7, 13, 17, 23, 26, 27, 28, 42,
44, 66, 92, 110, 111, 145
blood flow, 24, 60, 151
blood group, x, 40, 56, 57, 64, 65, 90, 91,
119
blood pressure, 106
blood supply, 107
body mass index (BMI), 8, 107, 128, 131,
132
body weight, 32, 33
bone, 94
bone marrow, 94
bones, 147
bowel, 145
brain, 144, 146, 147, 154
brain abscess, 146
breast cancer, vii, 1, 2, 3, 8, 9, 11, 12, 13,
14, 16, 17, 18, 138
C
calcium, 82
cancer, vii, 1, 2, 3, 4, 8, 9, 10, 14, 16, 18,
23, 106, 124
candidates, 60, 65
carbon, 124
cardiac disease, viii, 37, 40
cardiovascular disease(s), xi, 58, 65, 79, 81,
82, 86, 122, 123, 137
cardiovascular risk, 65, 79, 81, 126, 127,
128
cartilage, 94
case studies, 150
catheter, ix, 28, 35, 47, 49, 77
Caucasian population, 125, 133
Caucasians, xi, 57, 71, 122
causal relationship, 58
CBS, 96
CD8+, 94
cell signaling, 62
cell surface, 68
cellulitis, 49, 107
central nervous system, 147
cerebral amyloid angiopathy, 145
cerebral edema, 144, 150
cerebral hemorrhage, 148
chemical, viii, 5, 6, 21, 26, 27, 28
chemotherapy, vii, 1, 2, 6, 9, 16, 18, 106
children, 84, 105
chromosome, 75, 78, 124
chronic venous insufficiency, 44
cleavage, 56, 58, 59, 69, 71
clinical assessment, 26
clinical diagnosis, ix, 47, 49
clinical presentation, 142, 143, 144, 145,
151
clinical risk assessment, xi, 122, 133
clinical syndrome, 142
clinical trials, 111, 112, 113, 115
cloning, 93
coagulation, x, 2, 40, 56, 60, 61, 62, 66, 67,
72, 73, 75, 87, 92, 98, 100, 101, 104,
107, 110, 112, 113, 115, 118, 123
coagulation process, 60, 104
coding, 70, 72, 118
codon, 68
coffee, 138
colectomy, 6, 16
collagen, 66
collateral, 147
colon cancer, 135
color, 25, 29, 31, 108
combined effect, 134
common presenting symptoms, xii, 141
communication, 82
community, 45, 52, 74
https://t.me/med1917
Index
159
complement, 72
complexity, 65
compliance, 3
complications, vii, ix, x, 2, 3, 4, 16, 17, 18,
24, 26, 27, 28, 43, 44, 45, 48, 50, 51, 52,
103, 124, 139, 153
composition, 123
compounds, 106
compressibility, 25
compression, 3, 4, 5, 7, 9, 15, 28, 31, 33, 35,
41, 43, 51, 52, 114, 116, 143
congenital antithrombin III deficiency, 85
consciousness, 146
consensus, 5
conserving, 7
constituents, 106
consumption, 128
contraceptives, viii, 37, 40, 106, 109, 128,
130, 132, 134, 152
control group, xi, 44, 59, 122, 128, 130, 133
controlled trials, 16, 17
controversial, viii, 21, 22, 26, 59, 71, 109
controversies, 31
coronary arteries, 128
coronary artery disease, 58, 135, 137, 138
coronary heart disease, 71, 97, 99, 100, 108,
126
coronary thrombosis, 126
correlation, 81
correlations, viii, 38, 40
cortex, 145
cost, 7, 24
Costa Rica, xi, 121, 122, 123, 127, 128,
133, 134, 135, 136, 138
creatine, 128
creatinine, 111
Croatia, 137, 138
CSF, 145
CT, 26, 29, 36, 41, 108, 154, 155
CT scan, 44
culture, 71
culture medium, 68
CVD, 123, 124, 126, 127, 128, 134
cyclophosphamide, 9
cytokines, 40, 107
cytoplasmic tail, 71
cytosine, 125
cytotoxicity, 98
D
database, 8, 10, 13, 15, 16, 83, 86, 89
D-dimer, ix, 26, 31, 38, 41, 108, 115
deaths, vii, x, 1, 55, 74
deep venous thrombosis (DVT), viii, ix, 2,
3, 10, 11, 12, 17, 22, 23, 25, 26, 27, 28,
29, 31, 32, 33, 34, 36, 37, 38, 40, 41, 42,
43, 44, 45, 47, 48, 49, 50, 64, 67, 79, 93,
95, 97, 107, 108, 111, 113, 114, 123,
127, 153
defects, vii, x, 55, 64, 83, 87, 88, 110, 115,
124, 137, 150
deficiency(ies), 40, 60, 61, 62, 63, 64, 70,
77, 83, 84, 85, 86, 87, 88, 89, 105, 107,
108, 110, 113, 117, 118, 119, 124, 126,
127, 144, 149, 150
degradation, 147
dehydration, 145, 150
dementia, 126
demographic characteristics, 128, 129
dendritic cell, 94
Department of Health and Human Services,
14
deposition, 66, 67, 145
depression, 124, 138
depth, 65
detection, 25, 45, 62
diabetes, xi, 122, 123, 128, 130, 133
diagnostic criteria, 142, 143
diet, 113, 125, 126, 135
dietary intake, 138
differential diagnosis, 49
diffusion, 60, 147
digestion, 129
dilation, 41
dimorphism, 70, 89, 97, 99
disease progression, 114
diseases, xi, 98, 105, 107, 108, 114, 121,
122, 126, 133, 134
disequilibrium, 57, 59, 72
https://t.me/med1917
Index
160
disorder, 23, 49, 95, 123
disseminated intravascular coagulation, 62
distribution, 29, 132
DNA, 79, 124, 128, 129, 137
doctors, vii, x, 103
donors, 64, 128
doppler, 24, 25
dosing, 9, 120
drainage, 143, 145, 149, 154
drug abuse, ix, 47, 49
drugs, 28, 33, 42, 112
DWI, 147
dyslipidemia, 123
dyspnea, 108
E
edema, viii, 2, 38, 39, 40, 43, 50, 143, 147,
150, 151
education, 115
elderly population, 145
electroencephalography, 147
ELISA, 44, 108
emboli, 50
embolism, vii, x, 43, 45, 67, 97, 103
emergency, 39, 110, 111
encoding, 73, 124, 136, 138
endothelial cells, 67, 71, 98
endothelium, 40, 65
endotoxemia, 94
energy, 143
environment, 105
environmental factors, 124
enzymatic activity, 111
enzyme(s), 60, 97, 108, 124, 125, 126, 129,
136
enzyme-linked immunosorbent assay, 108
epidemiologic, 53
epidemiology, 74
epithelial cells, 94
equilibrium, 129, 132
ERA, 139
erythema, viii, ix, 38, 40, 47, 48
erythema nodosum, 49
estrogen, viii, ix, 8, 17, 38, 40, 47, 106, 109,
134, 135, 138
ethics, 128
ethnic groups, 109, 136
ethnicity, 119
etiology, xi, 39, 50, 103, 109, 110
Europe, x, 55, 125
evidence, ix, 3, 15, 30, 31, 32, 35, 44, 46,
48, 58, 66, 73, 81, 92, 97, 137, 149, 150
examinations, 108
excision, 9, 51, 52
exons, 63, 87, 124
exposure, 40
F
fainting, 108
false negative, 25
false positive, 24
families, 56, 63, 77, 79, 84, 87, 88, 89
family history, 48, 106, 109, 128, 130, 132,
134
feedback inhibition, 104
female patients, xi, 122, 127, 133, 134
fetal growth retardation, 108
fibrin, 41, 57, 58, 60, 61, 66, 67, 78, 81, 82,
104
fibrin degradation products, 41
fibrinogen, xi, 57, 58, 59, 78, 79, 80, 81, 82,
106, 122, 130, 132, 133, 134, 137
fibrinolysis, 17, 42, 59, 81, 82, 104
fibrinolytic, 40, 57, 91, 104
fibrosis, 43
fibula, 22
filters, 43, 46, 120
flight, 148
flights, 107
fluid, 146, 148
focal seizure, xii, 141
folate, 124, 125, 126, 127, 136, 139
folic acid, 126, 127
food, 127
formation, 8, 40, 50, 58, 60, 61, 77, 104,
107
https://t.me/med1917
Index
161
G
gangrene, 108
gastrocnemius, 22, 25, 30
gel, 51
gene expression, 61, 68, 72, 75
gene promoter, 68, 86
general anesthesia, 5
general surgery, 5, 7, 38
genes, x, 56, 58, 72, 73, 96, 124, 138
genetic background, 109
genetic defect, 115
genetic factors, 58, 105, 113, 126, 129
genetics, 73, 74, 79, 133
genitals, 48
genome, x, 56, 75, 80, 89, 90, 91, 101, 119
genotype, xi, 69, 90, 122, 125, 126, 127,
132, 134, 136, 138
genotyping, x, 56, 138
glucocorticoids, 107
glutamine, 56
glycosylation, 65
gravity, 39
growth factor, 94
guidelines, viii, xii, 3, 5, 7, 12, 14, 15, 21,
22, 26, 30, 31, 32, 35, 46, 119, 120, 142,
149, 150
H
haemostasis, 66, 79
haemostatic, x, 56, 58
half-life, 113
haplotypes, 57, 68, 99, 100
head injury, 146
headache, 146, 154
healing, 94
health, vii, x, 52, 98, 103
health care costs, 52
heart disease, 123
heart failure, 107
heart rate, 110
hematocrit, 39
hematoma(s), 7, 13, 17, 143, 144
hematopoietic stem cells, 94
hemiplegia, 145
hemoglobin, 147
hemoptysis, 108
hemorrhage, xii, 7, 24, 44, 111, 112, 114,
116, 142, 147, 148, 155
hemorrhagic stroke, 111
hemostasis, 17, 79, 81, 82, 104, 123
heritability, x, 56
high risk patients, 5, 25, 28, 44
hip replacement, 34, 35
Hispanic population, 125
history, ix, xi, 22, 23, 29, 30, 43, 47, 48, 49,
62, 106, 111, 113, 122, 123, 128, 130,
131
HIV, 73
homocysteine, 124, 125, 126, 127, 134, 135,
136, 137, 138, 139
homozygote, 125
hormone, viii, 37, 40, 115, 123, 134
hospitalization, vii, 1, 23
human, 59, 68, 71, 78, 82, 85, 87, 92, 93,
94, 96, 98, 100, 136, 137, 138
human neutrophils, 93
human skin, 94
Hunter, 92, 137, 154
hydrolysis, 82
hypercholesterolemia, xi, 122, 128, 130,
132, 133, 134
hypersensitivity, 24
hypertension, 123, 137, 146
hypotension, 145, 153
hypothesis, 23, 69
hypoxia, 39
I
IBD, 116
ICVT, viii, xii, 21, 22, 23, 26, 27, 28, 141,
142, 143, 144, 145, 146, 147, 148, 149,
150, 151
ideal, 7, 41
identification, x, 52, 56, 63, 66, 73, 119
images, 24, 147, 148, 155
https://t.me/med1917
Index
162
immobilization, viii, ix, 37, 40, 47, 49, 106,
123
immune response, 72
in vitro, 58, 68, 97, 125
in vivo, 17, 66, 104
incidence, vii, viii, x, 1, 2, 3, 11, 12, 13, 22,
24, 37, 38, 41, 42, 48, 85, 90, 99, 103,
105, 106, 117, 123, 135, 142
incomplete dominance, 125
India, 136
Indians, 139
individuals, xi, 2, 61, 62, 63, 64, 70, 72, 73,
89, 97, 103, 105, 106, 107, 110, 114,
115, 117, 123, 125, 145, 149
induction, 12
induration, ix, 47, 49
infarction, xii, 142, 143, 144, 147, 148, 151,
152
infection, ix, 47, 49, 51, 147
inferior vena cava, 41, 46, 114
inflammation, ix, 26, 47, 51, 63, 67, 72, 80,
85
inflammatory bowel disease, xii, 116, 141,
153
informed consent, 128
inhibition, 27, 42, 61, 70, 82, 87, 94
inhibitor, 8, 34, 40, 42, 44, 57, 60, 63, 72,
82, 87, 98, 113
initiation, 8, 9, 104
injury, 9, 24, 25, 39, 48, 85, 94, 104, 145
innate immunity, 91
insertion, 68, 95, 96
institutions, viii, 21, 22, 128
intercellular adhesion molecule, 65, 91
interface, 67
interference, 42
intervention, 108
intracerebral hemorrhage, 153
intracranial pressure, xii, 141, 144, 146
intravenously, 110
intron, 58, 68, 96
inversion, 78, 148
inversion recovery, 148
iodinated contrast, 24
ions, 82
Ireland, 79, 86, 97, 99, 100, 118
ischemia, 43, 111, 115
isolation, 143
J
Japan, 105
K
keratinocytes, 94
kinetics, 81
knee arthroplasty, 27, 33, 34
knees, 25
L
laboratory tests, 109
latissimus dorsi, 7, 10, 12
lead, viii, 2, 37, 39, 43, 49, 50, 63, 106, 112
leakage, 144
legs, 53
lesions, 107, 115, 146, 149, 150
lethargy, 146
leukemia, 98
lifetime, vii, 1
light, 11
liver, 113
liver disease, 63
loci, x, 56, 58, 59, 62, 65, 72, 75, 80, 86, 92
locus, 59, 62, 65, 66, 75, 78, 91, 92, 93, 119
longitudinal study, 7
low risk, 3, 4, 5, 28, 51
lumbar puncture, xii, 141, 145, 150, 153
lumen, 43
lumpectomy, vii, 1
lung cancer, 106
Luo, 92
lupus, 106, 149
lupus anticoagulant, 106, 149
lymph node, 7
lymphangitis, 49
lymphatic system, 107
lymphocytes, 94
https://t.me/med1917
Index
163
lysine, 57
lysis, 24, 81
M
magnetic resonance, 41
major histocompatibility complex, 96
majority, viii, 3, 11, 21, 22, 63, 110, 146,
151
malignancy, vii, viii, ix, 1, 37, 39, 40, 43,
47, 48, 49, 51, 106, 123
mammalian cells, 68
man, 99
management, viii, ix, xii, 17, 21, 22, 28, 31,
44, 48, 51, 114, 134, 142, 149, 151, 154,
155
Marx, 81
mass, 128, 144, 150
mastectomy, vii, 1, 3, 7, 8, 9, 10, 11, 12, 13,
14
maternal-embryo, 67
matrix, 94, 126
matrix metalloproteinase, 94
matter, 119
MB, 14, 29, 119, 128
measurement(s), 42, 70
median, 11
medical, vii, 1, 3, 5, 7, 14, 35
medication, 27, 115, 116, 145
medicine, 116
meningitis, 145, 146
meta analysis, 153
meta-analysis, 15, 32, 33, 34, 35, 38, 58, 65,
72, 79, 80, 90, 91, 97
metabolic pathways, 126
metabolism, 125, 126
methyl groups, 124
methylation, 124, 134
methylprednisolone, 145
mice, 59, 67, 82, 83, 94, 95, 98
migration, 2, 94
miscarriage, 109
mitochondria, 113
modelling, 119
models, 70, 82
modifications, 65
molecular weight, ix, 4, 5, 32, 33, 41, 42,
48, 64, 66, 150
molecules, 40, 62, 65, 107
morbidity, viii, 2, 13, 14, 17, 21, 23, 48
mortality, vii, viii, x, 1, 2, 3, 9, 13, 14, 21,
42, 55, 79, 86, 93, 94, 108, 112, 119, 138
mortality rate, x, 2, 9, 42, 55, 108
motif, 58
MR, 31, 33, 34, 147, 148, 149, 154, 155
MRI, 26, 147, 148, 151, 153, 155
mRNA, 58, 71, 78, 97, 105
multivariate analysis, viii, 38, 40
muscle contraction, 39
mutant, 135
mutation(s), xi, 12, 29, 40, 56, 57, 60, 61,
62, 63, 64, 67, 68, 69, 70, 76, 77, 83, 84,
85, 86, 87, 89, 95, 99, 100, 105, 110,
115, 117, 118, 122, 124, 135, 136, 137,
144, 149, 152
myeloproliferative disorders, 116
myocardial infarction, xi, 58, 76, 79, 95, 97,
99, 107, 108, 109, 118, 119, 122, 127,
138
N
nausea, 146
necrosis, 42, 108, 109, 113
nephrotic syndrome, xii, 107, 141, 145
nerve, 146
neuroimaging, xii, 142, 145, 146, 147, 149
neurological deficits, xii, 141, 145
neurosurgery, 106
neurotransmitters, 124
New England, 30
nonsense mutation, 61, 63
non-steroidal anti-inflammatory drugs, ix,
48, 51
nucleotide sequence, 68
nucleotides, 69, 124
null, 61
nutritional status, 138
https://t.me/med1917
Index
164
O
obesity, vii, viii, ix, xi, 1, 5, 8, 18, 37, 40,
47, 49, 107, 115, 122, 130, 132, 133, 134
obstruction, 24, 39, 144, 147
occlusion, 43, 110, 123, 143, 149, 152
oedema, 143, 144, 148
operations, 11, 14
oppression, 107
oral anticoagulation, xii, 35, 142, 150
organism, 51
organs, 114
outpatients, 5, 31, 88, 113
outreach, 24
overlap, 63
P
pain, viii, ix, 2, 38, 40, 43, 47, 48, 49, 50,
107
pancreatic cancer, 6, 16, 93
parietal lobe, 148
partial thromboplastin time, 42, 56, 100,
101, 111
participants, 128
pathogenesis, 45, 143
pathology, 52, 73
pathophysiological, 152
pathways, 14, 91, 123, 134, 147
patient care, 15
PCR, 125, 128, 129
penetrance, 91
penis, 48
PEP, 28, 35
percentile, viii, 37, 38, 59
perfusion, 111
peripheral blood, 128
permission, 6
pharmaceutical, 7, 8, 9
pharmacokinetics, 9
phenotype, 56, 58, 66, 67, 69, 84, 85, 92, 94
phenotypes, 65, 79, 86
phlebitis, ix, 48
phospholipids, 124
physicians, viii, 2, 3, 9, 21, 22, 30, 31, 32,
128
physiopathology, x, 56
placebo, 8, 51, 53, 138
plasma levels, 60, 61, 62, 63, 64, 65, 66, 69,
74, 79, 83, 86, 88, 92, 96, 125
plasminogen, 8, 40, 42, 104, 110
platelet aggregation, 49, 58, 82
platelet count, 40
platelets, 44, 59, 65, 66, 82, 93, 104
playing, 58
PM, 135, 139, 152
point mutation, 63, 68, 89, 98, 105
policy, 12
polycythemia, 145
polycythemia vera, 77
polymerase chain reaction, 125, 128
polymorphism(s), xi, 63, 68, 69, 70, 71, 72,
76, 78, 79, 81, 83, 86, 89, 97, 99, 100,
105, 109, 117, 122, 124, 125, 126, 127,
129, 130, 132, 133, 134, 135, 137, 138,
139
polypeptides, 58
popliteal veins, viii, 37, 39
population, viii, xi, 2, 11, 12, 13, 17, 22, 26,
29, 37, 38, 44, 57, 60, 61, 62, 63, 68, 71,
78, 80, 85, 88, 96, 99, 100, 105, 109,
114, 116, 117, 118, 122, 125, 126, 127,
129, 134, 136, 138, 142
population group, 126
portal vein, 108
preeclampsia, 100
pregnancy, viii, ix, 37, 40, 47, 49, 63, 106,
109, 115, 119, 123, 124, 139, 144
prevention, viii, ix, xi, 2, 3, 7, 12, 14, 15,
16, 17, 28, 30, 31, 32, 33, 35, 42, 44, 46,
48, 104, 114, 116, 120, 123
probability, 25, 26, 31, 69
proband(s), 84, 128
professionals, 155
progenitor cells, 98
prognosis, xii, 142, 150, 151, 152, 153
project, 61, 83, 93
proliferation, 94, 126
promoter, 62, 68, 86, 95
https://t.me/med1917
Index
165
propagation, viii, 21, 23, 25, 27, 60, 150
prophylactic, 2, 12, 19, 28, 73, 150
prophylaxis, viii, 2, 3, 4, 5, 6, 7, 8, 9, 11, 12,
13, 14, 15, 16, 17, 19, 21, 25, 27, 28, 34,
35, 36, 41, 42, 44, 46, 106
protease inhibitors, 104
protection, 61, 71
proteinase, 60
proteins, 60, 67, 72, 87, 106, 107, 113, 124
proteolysis, 61, 65, 91
prothrombin, 29, 40, 57, 58, 64, 70, 76, 77,
78, 97, 105, 118, 144, 150, 152
psoriasis, 80
PTT, 44, 56, 111
public health, x, 55, 115
puerperium, 106, 109, 115, 152
pulmonary embolism, vii, viii, x, 2, 21, 22,
30, 35, 37, 39, 41, 45, 59, 67, 93, 103,
114, 120, 123, 127
pulmonary hypertension, vii, x, 2, 103
purpura, 62, 108, 109, 119
Q
quality of life, 2
R
race, 113
radiation, 11, 18
radical mastectomy, 3, 7, 14
radiotherapy, 2, 106
randomized controlled clinical trials, 7
reactivity, 82
receptors, 67, 82, 104
recognition, 4, 62
recommendations, 4, 5, 7, 26, 149
reconstruction, vii, 1, 3, 9, 10, 11, 12, 13,
18, 19
recovery, 151
rectus abdominis, 10, 18
recurrence, ix, x, 9, 23, 26, 27, 30, 38, 42,
43, 50, 51, 55, 100, 106, 111, 113, 114,
150
red blood cells, 147
registries, 2
regression, 13, 129, 132
regression analysis, 13, 129
rehabilitation, viii, 38, 40
relatives, 60, 61, 63, 83, 118, 123
relevance, 22
reliability, 18
renal disease, viii, 38, 40
renal failure, 42, 111
replication, 73, 93
researchers, 2, 25
resection, 9
reserves, 124
residues, 62
resistance, 56, 58, 75, 77, 105, 118
resolution, ix, xii, 23, 48, 50, 51, 142
respiration, 41
respiratory failure, 107
response, 58, 60, 75, 82, 88, 118
restriction enzyme, 125
rheumatic diseases, 107
risk assessment, 3, 5, 15, 16
risk factors, vii, viii, x, xi, 2, 3, 4, 5, 8, 9,
13, 23, 25, 28, 38, 40, 44, 45, 49, 50, 51,
52, 55, 56, 57, 60, 73, 74, 79, 83, 90, 91,
99, 103, 105, 106, 107, 109, 115, 117,
122, 123, 126, 127, 128, 129, 130, 131,
132, 133, 134, 136, 137, 138, 150
risks, xi, 13, 87, 106, 115, 117, 118, 122,
130
routes, 43
S
safety, 32, 33, 34, 112, 113, 115
sedentary lifestyle, 115
seizure, 149
selective estrogen receptor modulator, 8
sensitivity, 24, 41, 108, 110, 147, 148
sensory symptoms, 146
sepsis, 98
serine, 60, 61, 71, 87
serotonin, 120
serum, 8, 128
https://t.me/med1917
Index
166
sex, 63, 88, 98, 128
SFT, 152
shortness of breath, 108
sialic acid, 91
signalling, 66
signals, 58, 148
signs, ix, 47, 49, 109, 110, 147, 149
sinuses, 39, 142, 143, 148, 151
skin, vii, viii, ix, 1, 2, 38, 40, 42, 47, 48,
108, 109, 113
skin cancer, vii, 1, 2
smoking, 115, 123, 124, 128, 137
smooth muscle, 126
smooth muscle cells, 94
SNP, 57, 58, 59, 61, 65, 66, 68, 69, 70, 72,
73, 125, 126, 127
Social Security, 127
society, 7
sodium, 111, 112, 113
soleus, 22
solution, 117
Spain, 55, 74
spinal cord, 145
spine, 45
SS, 29, 31, 136, 137
stability, 105, 113
standard deviation, 132
stasis, 39, 42, 45, 49, 143
Statistical Package for the Social Sciences,
129
status epilepticus, 146
stenosis, 128
steroids, 150, 155
stillbirth, 108, 109
stoichiometry, 64
stratification, 25, 52
streptokinase, 27, 32
stress, 109
stroke, xi, 36, 58, 79, 107, 108, 109, 111,
115, 122, 124, 127, 128, 129, 135, 136,
142, 152, 153, 155
structure, 81, 96, 106, 136, 147
subacute, 147
subarachnoid hemorrhage, 146, 154
subcutaneous injection, 112
substitution, 56, 57, 64, 65, 68, 69, 89, 125
substrate, 62, 84, 110, 125
substrates, 59, 62
subtraction, 149, 155
suicide, 60
sulfate, 40, 104, 111
supplementation, xi, 122, 134
surgical intervention, 7, 45
surgical removal, 52
surgical resection, 9
surveillance, viii, 21, 25, 31, 41, 45, 52, 113
survival, 3, 9, 14, 117
susceptibility, x, 56, 72, 74, 75, 76, 93, 101,
105, 117, 153, 155
swelling, 107, 143
symptoms, viii, ix, 2, 12, 24, 28, 38, 40, 43,
44, 48, 49, 50, 52, 108, 113, 116, 128,
145, 146
syndrome, vii, ix, x, 2, 23, 24, 43, 44, 48,
49, 50, 67, 93, 103, 108, 123, 145, 152,
153
synthesis, 124, 137
systemic lupus erythematosus, 49, 145
systolic blood pressure, 110
T
Taiwan, 118
tamoxifen, vii, 1, 8, 17
target, 11, 60, 73, 101, 129, 150
Task Force, 5
techniques, xi, 24, 103
technologies, x, 56, 134
temperature, 149
temporal lobe, 143
tenderness to palpation, ix, 47, 49
testing, 26, 45, 83, 112, 119, 120
therapeutic goal, 42
therapy, viii, ix, xi, 2, 3, 8, 9, 12, 15, 17, 23,
27, 30, 31, 32, 33, 35, 38, 40, 42, 44, 45,
46, 47, 51, 52, 96, 104, 106, 109, 115,
119, 123, 134, 145, 151, 153
thorax, 48
threonine, 71
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана